Cargando…

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives

Parkinsonism is a progressive motor disease that affects 1.5 million Americans and is the second most common neurodegenerative disease after Alzheimer’s. Typical neuropathological features of Parkinson’s disease (PD) include degeneration of dopaminergic neurons located in the pars compacta of the su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Sumit, Raymick, James, Imam, Syed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926438/ https://www.ncbi.nlm.nih.gov/pubmed/27338353 http://dx.doi.org/10.3390/ijms17060904

Ejemplares similares

The Use of Recently Developed Histochemical Markers for Localizing Neurotoxicant Induced Regional Brain Pathologies
por: Sarkar, Sumit, et al.
Publicado: (2014)

High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer’s Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations
por: Schmued, Larry, et al.
Publicado: (2019)

Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective
por: Behl, Tapan, et al.
Publicado: (2022)

Protein Kinases and Parkinson’s Disease
por: Mehdi, Syed Jafar, et al.
Publicado: (2016)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
por: Torres, Napoleon, et al.
Publicado: (2017)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives
por: Huang, Xing, et al.
Publicado: (2019)

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
por: Cruz-Vicente, Pedro, et al.
Publicado: (2021)

Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks
por: Ghosh, Nilanjan, et al.
Publicado: (2023)

NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives
por: McCann, Sarah K., et al.
Publicado: (2013)

Neuroprotective Strategies for Ischemic Stroke—Future Perspectives
por: Haupt, Matteo, et al.
Publicado: (2023)

Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics
por: Tania, Mousumi, et al.
Publicado: (2021)

PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
por: Pérez-Segura, Isaac, et al.
Publicado: (2023)

Neuroprotective strategies against calpain-mediated neurodegeneration
por: Yildiz-Unal, Aysegul, et al.
Publicado: (2015)

Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
por: Nielsen, Pernille Y. Ø., et al.
Publicado: (2023)

Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer's Disease
por: Minocha, Tarun, et al.
Publicado: (2022)

Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
por: Mao, Qi, et al.
Publicado: (2020)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
por: Shao, Yaping, et al.
Publicado: (2019)

The Neuroprotective Effects of Astaxanthin: Therapeutic Targets and Clinical Perspective
por: Fakhri, Sajad, et al.
Publicado: (2019)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Neuroprotective effect of carnosine against salsolinol-induced Parkinson's disease
por: Zhao, Jun, et al.
Publicado: (2017)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model
por: Imam, Syed Z., et al.
Publicado: (2013)

Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs
por: Rojas-Rodríguez, Felipe, et al.
Publicado: (2020)

Recent advances in perinatal neuroprotection
por: Singhi, Samata, et al.
Publicado: (2019)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives
por: Balakrishnan, Rengasamy, et al.
Publicado: (2021)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer’s and Parkinson’s Disease
por: Nomura, Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gqinhnroh65gppubiossjtd613